Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

INKTINKT
6 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in MINK THERAPEUTICS INC

Yes. Wells Fargo holds 2 shares of INKT (Mink Therapeutics), worth $23, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$23

Current Shares

2

Total Value Change

-$7,304

Total Shares Change

-846

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
2
-
$230.0%$11.69
17
2026-Q1
Exited
0
-100.0%
$00.0%$10.53
0
2025-Q4
New
20
-
$2230.0%$11.15
17
2025-Q3
Exited
0
-100.0%
$00.0%$14.00
0
2025-Q2
Increased
849
+0.1%
$6,2720.0%$7.39
11
2025-Q1
New
848
-
$7,3270.0%$8.64
25

Other major holders of INKT: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, DnB Asset Management AS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used